glp-1 for weight loss side effects medications have changed the conversation around management, but they're not without effects. The most common concerns include nausea, constipation, fatigue, muscle and nutritional inadequacies—many of which can be New research states weight loss

Once-weekly dosing: Tirzepatide is administered once a week by subcutaneous injection, which offers convenience and may improve treatment adherence

Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort

Your InCare provider will track inflammation levels, tissue health, and strength recovery over time to ensure real results

Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406)

Tirzepatide produced greater average weight reduction in the direct SURMOUNT-5 obesity trial, with mean weight loss of 20.2% compared with 13.7% for semaglutide at 72 weeks

The body is always adapting to our environment and trying to keep us healthy and safe